RecallDepth
Class II Ongoing

clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC 16714-849-02), c) 100-count bottles (NDC 16714-849-03), Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India

This recall is currently active, issued November 12, 2025. It was issued by Zydus Pharmaceuticals (Usa) Inc.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
October 22, 2025
Posted
November 12, 2025
Recall Number
D-0152-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.

Distribution

Nationwide in the US

Lot / Code Info

a) Lot # E408871, Exp Date: 10/2026; Lot # E405282, Exp Date: 06/2026; Lot # E400386, Exp Date: 12/2025 b) Lot # E408872, Exp Date: 10/2026; Lot # E405280, Exp Date: 06/2026 c) Lot # E408873, Exp Date: 10/2026; Lot # E405281, Exp Date: 06/2026; Lot # E400387, Exp Date: 12/2025

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls